翻訳と辞書 Words near each other ・ Fröberg conjecture ・ Frödinge ・ Frögärd i Ösby ・ Fröhlich ・ Fröhlich Prize ・ Fröhnd ・ Frédéric Swarts ・ Frédéric Sy ・ Frédéric Taddeï ・ Frédéric Talgorn ・ Frédéric Tatarian ・ Frédéric Teixido ・ Frédéric Thomas ・ Frédéric Théodore Faber ・ Frédéric Tranchand ・ Frédéric Triebel ・ Frédéric Vaccari ・ Frédéric Vercheval ・ Frédéric Vervisch ・ Frédéric Vichot ・ Frédéric Vieillot ・ Frédéric Villot ・ Frédéric Viret ・ Frédéric Vitoux ・ Frédéric Vitoux (tennis) ・ Frédéric Vitoux (writer) ・ Frédéric Volle ・ Frédéric Weis ・ Frédéric Xhonneux ・ Frédéric Y. Bois Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Frédéric Triebel ： ウィキペディア英語版 Frédéric Triebel Frédéric Triebel (born 20 November 1954) is a French immunologist who is best known for his 1990 discovery of the LAG3 immune control mechanism. Triebel worked through the 1990s in a collaboration between Institut Gustave Roussy and Merck Serono to establish LAG-3’s mechanism of action in T cells and dendritic cells. In 2001 he founded Immutep SA, a biotech company, to develop the therapeutic potential of LAG3. In 2014 this company was acquired by Prima BioMed, where Triebel remains Chief Scientific and Medical Officer. ==Early life and education== Frédéric Triebel was born in Douala, Cameroon, to Marcel and Odette Triebel. He completed his Doctor of Medicine degree at Poitiers University in 1981 and then a four-year clinical hematology fellowship in Paris hospitals. In 1983, Frédéric Triebel received the Gold Medal of the Paris Medicine University. In parallel, Triebel gained a PhD in Immunology at the University of Paris VI in 1985. His PhD thesis was in the field of immunogenetics, focused on the mechanisms that activate human antigen-specific T-cells. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Frédéric Triebel」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.